LON:ERGO Ergomed (ERGO) Share Forecast, Price & News GBX 1,004 -14.00 (-1.38%) (As of 04:35 PM ET) Add Compare Share Share Today's Range 1,004▼ 1,04850-Day Range 977▼ 1,08652-Week Range 910▼ 1,380Volume53,002 shsAverage Volume139,464 shsMarket Capitalization£506.02 millionP/E Ratio3,585.71Dividend YieldN/APrice TargetGBX 1,525 ProfileProfileAnalyst RatingsChartCompetitorsInsider TradesHeadlinesProfileAnalyst RatingsChartCompetitorsInsider TradesHeadlines About Ergomed (LON:ERGO) StockErgomed plc, together with its subsidiaries, provides clinical trial planning, management, and monitoring; and drug safety and medical information services in the United Kingdom, rest of Europe, the Middle East, Africa, North America, Asia, and Australia. It operates through two segments, Clinical Research Services and Pharmacovigilance. The company provides and manages clinical development, post-approval management, and pharmacovigilance services for pharmaceutical, biotechnology, and generics companies. It focuses on various therapeutic areas, including oncology, haematology, allergy, respiratory, and neurology/CNS, as well as develops orphan drugs. The company also provides site support services. The company was formerly known as Ergomed Clinical Research Limited and changed its name to Ergomed plc in June 2014. Ergomed plc was founded in 1997 and is headquartered in Guildford, the United Kingdom.Read More Receive ERGO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ergomed and its competitors with MarketBeat's FREE daily newsletter. Email Address ERGO Stock News HeadlinesMay 10, 2023 | americanbankingnews.comErgomed (LON:ERGO) Stock Price Passes Above Fifty Day Moving Average of $1,046.73May 8, 2023 | finance.yahoo.comIs Weakness In Ergomed plc (LON:ERGO) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?May 30, 2023 | Behind the Markets (Ad)"Unknown laser company making HUGE profit from Russia-Ukraine War"On February 24th, Russia invaded Ukraine. This caused major stock losses and soaring gas prices. But it also created a HUGE opportunity for savvy investors. There's an unknown laser company that's been profiting greatly from this war... ...and from another major conflict happening 3,000 miles away. Learn more here >>>April 12, 2023 | msn.comI just bought these beaten-up growth stocks for my ISAApril 8, 2023 | finance.yahoo.comInvesting in Ergomed (LON:ERGO) five years ago would have delivered you a 406% gainMarch 24, 2023 | americanbankingnews.comShore Capital Reiterates Hold Rating for Ergomed (LON:ERGO)March 23, 2023 | americanbankingnews.comErgomed (LON:ERGO) Rating Reiterated by Berenberg BankMarch 22, 2023 | finance.yahoo.comErgomed Full Year 2022 Earnings: Revenues Beat Expectations, EPS LagsMay 30, 2023 | Behind the Markets (Ad)[BREAKING] New "Living Missile" to Replace Nuclear MissilesCBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!March 20, 2023 | finance.yahoo.comEstimating The Fair Value Of Ergomed plc (LON:ERGO)February 26, 2023 | msn.comJust released: the 3 best small-cap stocks to buy now [PREMIUM PICKS]February 21, 2023 | marketwatch.comPharmacovigilance Outsourcing Market 2023 Size, Share, Growth, Analysis, Trends and Forecast to 2028February 20, 2023 | finance.yahoo.comIf EPS Growth Is Important To You, Ergomed (LON:ERGO) Presents An OpportunityJanuary 25, 2023 | morningstar.comEasyJet Shares Jump After Upbeat 1Q, Strong OutlookJanuary 25, 2023 | marketwatch.comErgomed Sees 2022 Adjusted Earnings Meeting Market Views; Names New CFOJanuary 23, 2023 | finance.yahoo.comWhen Should You Buy Ergomed plc (LON:ERGO)?December 28, 2022 | uk.finance.yahoo.comErgomed plc (ERGO.L)November 28, 2022 | finance.yahoo.comAre Robust Financials Driving The Recent Rally In Ergomed plc's (LON:ERGO) Stock?November 21, 2022 | markets.businessinsider.comErgomed (ERGO): Two key management changesNovember 17, 2022 | marketwatch.comErgomed Names Jonathan Curtain as Deputy CFOOctober 30, 2022 | finance.yahoo.comThe 9.0% return this week takes Ergomed's (LON:ERGO) shareholders five-year gains to 484%October 10, 2022 | finance.yahoo.comIs There An Opportunity With Ergomed plc's (LON:ERGO) 29% Undervaluation?October 4, 2022 | markets.businessinsider.comErgomed (ERGO): Poised for a strong FY22September 26, 2022 | yahoo.comGlobal Rare Disease Genetic Testing Market to Reach $2.52 Billion by 2030September 16, 2022 | yahoo.comGlobal Rare Disease Genetic Testing Market Report 2022: Government & Regulatory Support for Rare Disease Diagnosis to Drive GrowthSeptember 13, 2022 | finance.yahoo.comDoes Ergomed (LON:ERGO) Deserve A Spot On Your Watchlist?September 8, 2022 | markets.businessinsider.comDeka Biosciences Appoints Chief Medical Officer and Vice President of Clinical OperationsSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive ERGO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ergomed and its competitors with MarketBeat's FREE daily newsletter. Email Address ERGO Company Calendar Last Earnings9/18/2017Today5/30/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolLON:ERGO CUSIPN/A CIKN/A Webwww.ergomedplc.com Phone+44-1483-503205FaxN/AEmployees1,371Year FoundedN/APrice Target and Rating Average Stock Price ForecastGBX 1,525 High Stock Price ForecastGBX 1,600 Low Stock Price ForecastGBX 1,450 Forecasted Upside/Downside+48.8%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)GBX 0.28 Trailing P/E Ratio3,660.71 Forward P/E Ratio20.66 P/E GrowthN/ANet Income£14.98 million Net Margins10.31% Pretax MarginN/A Return on Equity19.72% Return on Assets10.91% Debt Debt-to-Equity Ratio3.43 Current Ratio1.50 Quick Ratio1.22 Sales & Book Value Annual Sales£145.26 million Price / Sales3.56 Cash FlowGBX 18.75 per share Price / Cash Flow54.67 Book ValueGBX 168 per share Price / Book6.10Miscellaneous Outstanding Shares50,400,000Free FloatN/AMarket Cap£516.60 million OptionableNot Optionable Beta0.83 Key ExecutivesDr. Miroslav Reljanovic (Age 64)Founder & Exec. Chairman Comp: $641.1kMr. Richard T. Barfield (Age 65)CFO & Exec. Director Comp: $438.78kMr. Michael William Spiteri (Age 62)Chief Transformation & Technology Officer Comp: $60kMr. Shaun HopgoodChief Information OfficerDr. Michael ForstnerHead of Risk Management & PharmacoepidemiologyMs. Sally AmanuelPres of PrimeVigilanceDr. Gordana TonkovicPres of Clinical ResearchMs. Ronel SteynSr. VP of Global Devel.Keith ByrneSr. Vice-Pres of Capital Markets & StrategyJonathan CurtainDeputy CFOMore ExecutivesKey CompetitorsPureTech HealthLON:PRTCSilence TherapeuticsLON:SLNOxford BiomedicaLON:OXBHorizon Discovery Group plc (HZD.L)LON:HZDVerona Pharma plc (VRP.L)LON:VRPView All CompetitorsInsidersRichard BarfieldSold 125,000 sharesTotal: £168.13 M ($1,345.00/share)Richard BarfieldSold 25,000 sharesTotal: £29.25 M ($1,170.00/share)View All Insider Transactions ERGO Stock - Frequently Asked Questions Should I buy or sell Ergomed stock right now? 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Ergomed in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ERGO shares. View ERGO analyst ratings or view top-rated stocks. What is Ergomed's stock price forecast for 2023? 3 analysts have issued 12-month target prices for Ergomed's shares. Their ERGO share price forecasts range from GBX 1,450 to GBX 1,600. On average, they predict the company's stock price to reach GBX 1,525 in the next year. This suggests a possible upside of 48.8% from the stock's current price. View analysts price targets for ERGO or view top-rated stocks among Wall Street analysts. How have ERGO shares performed in 2023? Ergomed's stock was trading at GBX 1,272 at the start of the year. Since then, ERGO shares have decreased by 19.4% and is now trading at GBX 1,025. View the best growth stocks for 2023 here. How were Ergomed's earnings last quarter? Ergomed plc (LON:ERGO) posted its quarterly earnings results on Monday, September, 18th. The company reported $1.20 EPS for the quarter. The business had revenue of $22.91 million for the quarter. Ergomed had a trailing twelve-month return on equity of 19.72% and a net margin of 10.31%. What other stocks do shareholders of Ergomed own? Based on aggregate information from My MarketBeat watchlists, some companies that other Ergomed investors own include Dicerna Pharmaceuticals (DRNA), AbbVie (ABBV), Axsome Therapeutics (AXSM), FuelCell Energy (FCEL), NIO (NIO), Science Applications International (SAIC), Northern Dynasty Minerals (NAK), Tilray (TLRY), Agilent Technologies (A) and American Express (AXP). What is Ergomed's stock symbol? Ergomed trades on the London Stock Exchange (LON) under the ticker symbol "ERGO." How do I buy shares of Ergomed? Shares of ERGO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What is Ergomed's stock price today? One share of ERGO stock can currently be purchased for approximately GBX 1,025. How much money does Ergomed make? Ergomed (LON:ERGO) has a market capitalization of £516.60 million and generates £145.26 million in revenue each year. The company earns £14.98 million in net income (profit) each year or GBX 0.28 on an earnings per share basis. How many employees does Ergomed have? The company employs 1,371 workers across the globe. How can I contact Ergomed? Ergomed's mailing address is 26-24 Frederick Sanger Road, GUILDFORD, GU2 7YD, United Kingdom. The official website for the company is www.ergomedplc.com. The company can be reached via phone at +44-1483-503205. This page (LON:ERGO) was last updated on 5/30/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ergomed plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.